TheraVet SA reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 1.6 million compared to EUR 1.94 million a year ago. Revenue was EUR 2 million compared to EUR 2.19 million a year ago.

Net loss was EUR 2.32 million compared to EUR 1.34 million a year ago. Basic loss per share from continuing operations was EUR 0.718.